Research
Westbourne Medical Centre is an active research practice – part of The Dorset Primary Care Clinical Research Group. We are also part of the newly formed Dorset Primary Care – Commercial Research Delivery Centre.
This means that we conduct research, both academic and commercial, with the aim of providing interesting and beneficial study opportunities to our patients.
We have a Research team, led by one of our partners, Dr Tom Linton. The team also includes Dr Goswami and two experienced research nurses, Sarah Orr, and Debbie Branney.
The trials are either funded by National Institute of Health Research (NIHR) or by commercial companies. We work within South West Central Regional Research Delivery Network.
We are also looking to develop our research services and collaborate further with other local GP surgeries or care providers in our local area. The aim is to increase the amount of research opportunities available to our patients. Our current partnerships allow to us work closely with Adam Practice, Shore Medical, Quarterjack Surgery and Wareham Surgery.
https://nhsdorset.nhs.uk/news/dorsets-first-specialist-primary-care-commercial-research-centre/
Current Studies:
Here is a sample of our current studies that we are running. If you are eligible for a study, you should have been contacted, however depending on your contact preferences this may not always be the case. If you have not heard from us but think you might be eligible and are keen to participate, then please get in touch.
COAT (Cellulitis Optimal Antibiotic Treatment)– A study looking to find out whether 5 days or 7 days are the optimal length of antibiotics for patients with cellulitis (a skin infection) in the leg.
SAFE-D – a study looking to test and develop a new screening or biomarker test for pancreatic cancer in those who develop Type 2 Diabetes. We know that new Type 2 Diabetics have ten times higher than average risk of developing pancreatic cancer.
https://www.southampton.ac.uk/ctu/trialportfolio/listoftrials/safe-d.page
LUNA menstrual migraine study – a study looking at ladies between 18 and 50 years of age who suffer with hormonally triggered migraines around the time of their period. The study is looking at whether a medication which is already used for migraine sufferers may work for this group of patients as well. The medication on trial is taken only for 7 days around the time of period onset. The participants are divided into two groups for the first half of the study, one half receives the medication and one half a placebo, but then in the second half of the study all participants receive the actual medication. The study lasts around 11 months in total.
TRIUMPH 8 – a study testing a new GLP1 injectable weight loss medication in people who are overweight or have obesity. The study is testing the effectiveness and safety of a new weight loss medication and lasts for over 1 year in total.
MOVE-Lp(a) – a study testing a new medication that lowers Lipoprotein(a) levels. Lp(a) is associated with an increased risk of cardiovascular disease, and the study is investigating whether a medication to lower Lp(a) reduces the risk of having a heart attack or stroke, and therefore improves outcomes compared to placebo. The study may last up to 5 years in total.